HRMY vs SRPT · P/E 14, rev $476.7M vs rev $1.13B
Harmony Biosciences Holdings (HRMY) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported HRMY revenue for 2026-06-30 was $476.7M. Net income was $107.9M. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
HRMY currently screens at market cap $1.96B and trailing P/E 13.6. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the HRMY and SRPT stock pages for the full models.
Not investment advice.